06Jun/13

Celgene Corporation gets USFDA approves for REVLIMID – Moneycontrol.com


Moneycontrol.com

Celgene Corporation gets USFDA approves for REVLIMID
Moneycontrol.com
The approval was based on the results of MCL-001, a phase II, multi-center, single arm, open label study evaluating lenalidomide in 134 patients with MCL who had received prior treatment with rituximab, cyclophosphamide, an anthracycline (or
FDA Approves Lenalidomide for the Treatment of Mantle Cell LymphomaOncLive
Revlimid Gains New Lymphoma IndicationMonthly Prescribing Reference
FDA clears Celgene’s sNDA for mantle cell lymphoma drug candidatePharmaceutical Business Review

all 16 news articles »

06Jun/13

Paris student left brain-dead in far-right attack – The Local.fr


Gay Star News

Paris student left brain-dead in far-right attack
The Local.fr
“Violently beaten to the ground by a group of activists from the extreme right, manifestly from the group JNR (Jeune Nationaliste Revolutionnaire), left motionless, he was declared this evening to be in a state of brain death at Pitié-Salpêtrière
Gay rights activist, 18, left brain dead after attack in FranceGay Star News
French student, 18, left brain dead after attack by mob of far-right skinheads Daily Mail

all 44 news articles »